Clinical Trial Update: Endometrial Cancer Biomarker Changes Following Exposure to Metformin [Phase 2]

View source ↗

Summary

Phase 2 trial investigating biomarker changes in endometrial cancer after metformin exposure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Jewish General Hospital | Conditions: Endometrial Cancer | Phase 2 | Status: WITHDRAWN